The Clinical Laboratory Services Market is Witnessing Significant Growth Opportunities in The Coming Years

The global clinical laboratory services market is projected to reach USD 146.41 Billion by 2022 from USD 113.44 Billion in 2017, at a CAGR of 5.2%. The rising demand for early and accurate disease diagnosis, growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, and advancements in clinical diagnostic techniques are the key factors driving the growth of the market.

Download FREE Pdf Broucher of the Clinical Laboratory Services Market @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=554 ​​​​​​​

This research study of clinical laboratory services market involves the extensive usage of secondary sources, directories, and databases (such as, Bloomberg Business, Factiva, and Dun & Bradstreet), in order to identify and collect information useful for this technical, market-oriented, and financial study of the market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.



This report broadly segments the clinical laboratory services market into specilaty, provider, and region. On the basis of specialty, the market is categorized into clinical chemistry, microbiology, hematology, immunology, cytology, genetic, and drugs of abuse testing.

Based on provider, the market is categorized into three segments, namely, independent and reference laboratories, hospital-based laboratories; and nursing and physician office-based laboratories.

This report covers the market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, Europe is expected to command the largest share of the market in 2017.

Government initiatives to promote awareness about preventive screening, growing public and private funding for research on the development of clinical laboratory tests, and increasing adoption of genome-based laboratory tests are driving the market in this region. However, Asia Pacific is expected to register the highest growth rate during the forecast period due to rising healthcare expenditure, increasing number of hospitals and clinical diagnostic laboratories in India and China, and strengthening research base for clinical laboratory testing procedures across India, China, and Japan.

Request for FREE Sample Report with all Graphs and Charts Related to it @: https://www.marketsandmarkets.com/requestsampleNew.asp?id=554


Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), and Cerba HealthCare (France) were some of the other major players in this market.

Comments